Chemicals and pharmaceuticals · LOOP

Loop Industries, Inc.

12 filings mentioning 2 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
2topics disclosed
Chemicals and pharmaceuticalsindustry
A8based in

Across 12 filings we hold, Loop Industries, Inc. has written down 2 of the topics we track. That places it 5 of 17 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

LOOP Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something Loop Industries, Inc. has written into a filing. Not what they said. What applies once they have said it.

ISO 27001:202242
COSO Internal Control9
PCAOB AS 22014
IFRS 172

4 frameworks, 57 controls between them, deduplicated across topics.

Tell me when Loop Industries, Inc. files something new

One email when there is a new SEC filing, naming what it is and what our corpus says it puts in scope. Nothing else, and one click to stop.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Internal Control302025-07-03
Restatement32022-06-02

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24
25

Recent filings

FiledFormItem
2025-07-038-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2024-07-318-KRegulation FD disclosure, Financial statements and exhibitsfiling
2024-07-158-KResults of operations, the earnings release, Regulation FD disclosure, Financial statements and exhibitsfiling
2024-06-048-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2024-05-308-KResults of operations, the earnings release, Regulation FD disclosure, Financial statements and exhibitsfiling
2024-05-078-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2024-01-178-KResults of operations, the earnings release, Regulation FD disclosure, Financial statements and exhibitsfiling
2023-10-168-KResults of operations, the earnings release, Regulation FD disclosure, Financial statements and exhibitsfiling
2023-07-128-KResults of operations, the earnings release, Regulation FD disclosure, Financial statements and exhibitsfiling
2023-05-188-KResults of operations, the earnings release, Regulation FD disclosure, Financial statements and exhibitsfiling
2023-05-028-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2023-03-298-KRegulation FD disclosure, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition